605 Systemically administered HER2-targeted ISACs provoke a rapid, local response that engages the innate and adaptive arms of the immune system to eradicate tumors in preclinical... by Marcin Kowanetz, Po Ho, Shelley Ackerman, Heidi LeBlanc, David Dornan, Michael Alonso, Cecelia Pearson, Andrew Luo, Richard Laura, Justin Kenkel, LIsa Blum, Angela Luo, Matthew Zhou, Joshua Gregorio, Brian Safina